CEFOBID Side Effects

6532366-0 | Chest Discomfort, Flushing, Hypersensitivity
on Jan 03, 2010 Female patient from EGYPT , 16 years of age, was diagnosed with pneumonia (What is pneumonia?), diabetes mellitus and was treated with Cefobid (View Usage). Patient experienced the following unwanted or unexpected effects: chest discomfort, flushing, hypersensitivity. Cefobid dosage: 0.25 Mg/kg, 2x/day. During the same period patient was treated with AMPICILLIN SODIUM/SULBACTAM SODIUM (1.5 G, 2x/day) (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), INSULIN (Unk) (View Insulin Review and Insulin Label ).

6531496-7 | Cardiac Arrest, Chest Discomfort, Hypersensitivity, Shock
Patient was taking Cefobid (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), chest discomfort, hypersensitivity, shock on Jan 03, 2010 from EGYPT Additional patient health information: Male patient , 14 years of age, was diagnosed with febrile neutropenia, systemic mycosis and. Cefobid dosage: 0.5 G, 3x/day. During the same period patient was treated with AMPICILLIN SODIUM/SULBACTAM SODIUM (1.5 G, 2x/day) (View Ampicillin Sodium/sulbactam Sodium Review and Ampicillin Sodium/sulbactam Sodium Label ), PARACETAMOL (Unk) (View Paracetamol Review and Paracetamol Label ), SPORANOX (Unk) (View Sporanox Review and Sporanox Label ). Patient was hospitalized.

6296055-2 | Anaphylactic Shock
Adverse event was reported on Jul 23, 2009 by a Female patient taking Cefobid (View Usage) (Dosage: 1 G, 1x/day) was diagnosed with cellulitis (What is cellulitis?) and. Location: JAPAN , 59 years of age, After Cefobid was administered, patient had the following side effects: anaphylactic shock.

6280385-4 | Acute Respiratory Failure
on Jul 14, 2009 Female patient from JAPAN , 59 years of age, was diagnosed with cellulitis (What is cellulitis?) and was treated with Cefobid (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory failure. Cefobid dosage: 1 G, 1x/day.


4954034-9 | Toxic Epidermal Necrolysis
on Mar 08, 2006 Male patient from MALAYSIA , 24 years of age, was diagnosed with sepsis (What is sepsis?) and was treated with Cefobid (View Usage). Patient had the following side effects: toxic epidermal necrolysis. Cefobid dosage: (2 Gram) Intravenous.

4920573-X | Cardiac Arrest, Rash
Patient was taking Cefobid (View Usage). After Cefobid was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), rash (What is rash?) on Feb 05, 2006 from EGYPT Additional patient health information: Female patient , 67 years of age, was diagnosed with lower respiratory tract infection and. Cefobid dosage: 2 Gram (1 Gram, 2 In 1d), Intravenous. During the same period patient was treated with DIFLUCAN (View Diflucan Review and Diflucan Label ), INSULIN (View Insulin Review and Insulin Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), RYTHMONORM(PROPAFENONE HYDEROCHLORIDE) (View Rythmonorm(propafenone Hyderochloride) Review and Rythmonorm(propafenone Hyderochloride) Label ).

4788837-0 | Cardio-respiratory Arrest, Vomiting
Adverse event was reported on Sep 21, 2005 by a Female patient taking Cefobid (View Usage) (Dosage: 2 Gram (1 Gram, Bid Interval: Every Day), Intravenous) was diagnosed with prophylaxis and. Location: EGYPT , 52 years of age, Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, vomiting.

4546369-9 | Anaphylactic Shock
on Dec 25, 2004 Male patient from , 50 years of age, was diagnosed with osteomyelitis and was treated with Cefobid (View Usage). Patient had the following side effects: anaphylactic shock. Cefobid dosage: 2 Gram (1 Gram, 2 In 1 D), Intravenous.